X4 Pharmaceuticals (XFOR) Selling, General & Administrative (2017 - 2025)
X4 Pharmaceuticals (XFOR) Selling, General & Administrative (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,839.48 Bn | 65,839.20 Bn | - | -10.08 Mn |
| 2 | Nanobiotix | 1,914.07 Bn | 1,914.01 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | 2.17 Mn |
| 4 | BeOne Medicines | 469.68 Bn | 464.89 Bn | 1.35 Bn | 555.10 Mn |
| 5 | Vertex Pharmaceuticals | 122.76 Bn | 115.51 Bn | 2.59 Bn | 493.70 Mn |
| 6 | Regeneron Pharmaceuticals | 70.40 Bn | 61.65 Bn | 3.31 Bn | 647.70 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | 17.02 Mn |
| 8 | Argenx Se | 55.88 Bn | 50.69 Bn | 1.41 Bn | 1.13 Bn |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn | 322.55 Mn |
| 10 | X4 Pharmaceuticals | 163.88 Mn | -53.16 Mn | 2.20 Mn | 7.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.38 Mn |
| Sep 30, 2025 | 11.59 Mn |
| Jun 30, 2025 | 9.53 Mn |
| Mar 31, 2025 | 15.02 Mn |
| Dec 31, 2024 | 15.15 Mn |
| Sep 30, 2024 | 15.66 Mn |
| Jun 30, 2024 | 13.28 Mn |
| Mar 31, 2024 | 17.44 Mn |
| Dec 31, 2023 | 9.93 Mn |
| Sep 30, 2023 | 8.13 Mn |
| Jun 30, 2023 | 10.20 Mn |
| Mar 31, 2023 | 7.24 Mn |
| Dec 31, 2022 | 6.56 Mn |
| Sep 30, 2022 | 6.04 Mn |
| Jun 30, 2022 | 6.75 Mn |
| Mar 31, 2022 | 7.66 Mn |
| Dec 31, 2021 | 7.14 Mn |
| Sep 30, 2021 | 5.93 Mn |
| Jun 30, 2021 | 5.80 Mn |
| Mar 31, 2021 | 5.83 Mn |